DeNA has updated its high price.
The new high price stocks on the Main Board of the Tokyo Stock Exchange are Shimizu Construction <1803> and Yondenko <1939>, with a total of 55 stocks. The new low price stocks on the Main Board are Kurazushi <2695> and Tatsumo <6266>, with a total of 3 stocks. "Main Board" "Standard Board" "Growth Board" new highs new lows new highs new lows new highs new lows 12/30 553 303 189 12/27 583 297 111 12/26 303 234 762 12/25 211 913 567 44 12/24 19.
Stocks that moved or were traded in the first half of the session.
*Makino Milling Machine <6135> 10,750 yen - Nidec Corporation Sponsored ADR continues to narrow the gap towards the TOB price. *Weathernews <4825> 3,775 +450 appreciates the expanded operating profit margin in the first half of the year. *Marumae <6264> 1,695 +178 welcomes the steady recovery in Q1 earnings. *Nomura Micro Science <6254> 2,279 +235 the flow of short covering appears to be getting stronger. *Fixstars <3687> 2,086 +189 electronic component.
List of stocks breaking through clouds (weekly chart) (part 1)
○ List of stocks that have surpassed the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Main Board <1332> Nissui 900 894.75 822 <1375> Yuki Country Maitake 1060 1018.75 1020 <1433> Bestella 1070 1011.25 1038 <1663> K&O Energy 3635 3483.75 3163 <1812> Kajima 2892 2823.
List of conversion stocks (Part 1) [Parabolic Signal Conversion Stocks]
○List of stocks undergoing Buy conversion in the market Code Stock Name Closing Price SAR Tokyo Main Board <1301> Kiyokyo 4115 3945 <1332> Nissui 900873 <1377> Sakata Seed 34703370 <1726> Br. HD 346330 <1802> Obayashi Corporation 21012025 <1808> Haseko Corporation 20491980 <1820> Nishimatsu Construction 52485066 <1887> Japan National.
DWTI, Architects SJ and others.
<1447> Acquisition and cancellation of all remaining subscription rights of the 4th series (with exercise price adjustment clause) of SAAFD. <3557> Large exercise of the 9th subscription rights (with exercise price adjustment clause) of U&C from the 4th, number of shares delivered, 0.07 million, 2000 shares. <4576> Approval obtained in Thailand for the glaucoma and ocular hypertension treatment "Grau Alpha combination eye drops (domestic product name)" of DWTI. <4586> Termination of joint research contract with Medrec Fanpepp. <4881> Soleasia's downward revision, current period operations.
December 27 [Today's Investment Strategy]
[Selected Stocks by Fisco] 【Material Stocks】 Kaken Pharmaceutical <4521> 4174 yen (12/26) Main products include the nail fungus treatment 'Klenafin' and the joint function improvement drug 'Alts'. The company announced the signing of a contract granting Johnson & Johnson exclusive rights for the development, manufacturing, and commercialization globally of the 'STAT6 Program', which is being developed as a next-generation oral treatment for type 2 inflammatory diseases (such as atopic dermatitis and asthma).